title: Letter by Seitz and Beurtheret regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing risk analysis from the randomized evaluation of long-term anticoagulant therapy study".
authors.affiliation: Electrophysiology Unit of Saint Joseph Hospital Marseille, France.
authors.forename: Julien
authors.initials: J
authors.lastname: Seitz
authors.affiliation: Cardiac Surgery Department, Saint Joseph Hospital, Marseille, France.
authors.forename: Sylvain
authors.initials: S
authors.lastname: Beurtheret
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D000991:Antithrombins / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000401:mortality*; D001562:Benzimidazoles / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D014859:Warfarin / Q000008:administration & dosage*; D015091:beta-Alanine / Q000031:analogs & derivatives*
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin